Ampio Pharmaceuticals, Inc. (AMPE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalData
33 Pages - GLDATA54223
$250.00

Summary

Ampio Pharmaceuticals, Inc. (Ampio), formerly Chay Enterprises, Inc., is a biopharmaceutical company that discovers and develops novel therapeutic candidates for inflammatory conditions. The company offers products for the treatment of osteoarthritis of the knee and for the treatment of diabetic macular edema. Its products include low molecular weight fraction of human serum albumin (HSA) and ultra-low dose of danazol. Ampio provides pre-clinical and clinical studies for crohn’s disease, chronic obstructive pulmonary disease and other chronic inflammatory conditions. The company’s ultra-low dose of danazol is for the oral treatment of diabetic macular edema. It partners with biopharmaceutical companies. Ampio is headquartered in Englewood, Colorado, the US.

Ampio Pharmaceuticals, Inc. (AMPE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Ampio Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Ampio Pharmaceuticals, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Ampio Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Ampio Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Ampio Pharmaceuticals, Inc., Medical Devices Deals, 2010 to YTD 2016 10
Ampio Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 11
Ampio Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deal Details 12
Merger 12
Rosewind Merges with Vyrix Pharma and Luoxis Diagnostics in Reverse Merger Transaction 12
Chay Enterprises Completes Merger With DMI Life Sciences 13
Licensing Agreements 14
FBM FARMA Industria Farmaceutica Enters Into Licensing Agreement With Ampio Pharma For Zertane 14
Ampio Pharma Enters Into Licensing Agreement With Daewoong Pharma For Zertane 15
Equity Offering 17
Ampio Pharma Plans to Raise up to USD25 Million in Public Offering of Shares 17
Ampio Pharma Completes Public Offering Of Shares For US$68.4 Million 19
Ampio Pharma Completes Private Placement Of Shares For US$25.3 Million 20
Ampio Pharma Completes First Tranche Of Private Placement Of Shares 21
Ampio Pharma Completes Public Offering Of Shares For US$17 Million 22
Ampio Pharma Completes Private Placement Of Common Stock For US$9.4 Million 24
Ampio Pharma Completes Private Placement For US$12.7 Million 25
Ampio Pharma Completes Private Placement Of US$0.58 Million 27
Acquisition 28
Ampio Pharma Acquires DMI BioSciences 28
Ampio Pharmaceuticals, Inc. - Key Competitors 30
Key Employees 31
Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
Ampio Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Key Facts, 2015 1
Ampio Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Ampio Pharmaceuticals, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Ampio Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Ampio Pharmaceuticals, Inc., Deals By Therapy Area, 2010 to YTD 2016 8
Ampio Pharmaceuticals, Inc., Medical Devices Deals, 2010 to YTD 2016 10
Ampio Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 11
Rosewind Merges with Vyrix Pharma and Luoxis Diagnostics in Reverse Merger Transaction 12
Chay Enterprises Completes Merger With DMI Life Sciences 13
FBM FARMA Industria Farmaceutica Enters Into Licensing Agreement With Ampio Pharma For Zertane 14
Ampio Pharma Enters Into Licensing Agreement With Daewoong Pharma For Zertane 15
Ampio Pharma Plans to Raise up to USD25 Million in Public Offering of Shares 17
Ampio Pharma Completes Public Offering Of Shares For US$68.4 Million 19
Ampio Pharma Completes Private Placement Of Shares For US$25.3 Million 20
Ampio Pharma Completes First Tranche Of Private Placement Of Shares 21
Ampio Pharma Completes Public Offering Of Shares For US$17 Million 22
Ampio Pharma Completes Private Placement Of Common Stock For US$9.4 Million 24
Ampio Pharma Completes Private Placement For US$12.7 Million 25
Ampio Pharma Completes Private Placement Of US$0.58 Million 27
Ampio Pharma Acquires DMI BioSciences 28
Ampio Pharmaceuticals, Inc., Key Competitors 30
Ampio Pharmaceuticals, Inc., Key Employees 31
Ampio Pharmaceuticals, Inc., Subsidiaries 32

List of Figures
Ampio Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Ampio Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Ampio Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Ampio Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Ampio Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Ampio Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Ampio Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Ampio Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Ampio Pharmaceuticals, Inc., Medical Devices Deals, 2010 to YTD 2016 10

$250.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838